Bone Replacement Market size will experience high growth from 2022 to 2028. The prevalence of osteoarthritis is on the rise, bone replacement procedures will pick up pace worldwide. These procedures require bone graft substitutes including allografts, auto-grafts, and other synthetic materials such as ceramics. With reduced procedural costs, lower recovery times, and higher success rate of bone grafting, there is a marked rise in the number of individuals opting for these treatments.
One of the key drivers of the bone replacement products market is the rising incidence of sports injuries. According to the American Academy of Pediatrics, nearly 3.5 million children aged 14 and below are hurt every year while playing sports and engaging in recreational activities in the U.S. Over 775,000 children are admitted to the emergency units in hospitals for sports-related injuries resulting from collisions, falls, and overexertion.
Considering the high incidence of serious sports injuries, intervention by sports injury specialists is frequently needed for treating a damaged or injured joint of the ankle, hip, knee, wrist, elbow, and shoulder. The rising popularity of bicycling, baseball, basketball, skateboarding, ice hockey, snow skiing, and similar activities, amongst children and adults alike, is expected to drive the bone grafts and substitutes market over the next six years.
The bone replacement market share from the allografts segment is slated to grow at an appreciable CAGR between 2022 and 2028. As these products are extensively used in orthopedic surgeries, the increasing number of these procedures is paving the way for the market outlook. As per the 2021 figures published by World Health Organization, more than 1.71 billion individuals across the world suffer from musculoskeletal conditions. The prevalence of musculoskeletal disorders is expected to rise further due to faster rate of ageing and increasing population density.
The ankle and foot replacement segment in the bone replacement market is exhibiting a stable growth, due to the rising incidence of osteoporosis, rheumatoid arthritis, and osteoarthritis. Advancements in medical technologies have ensured minimal risks and complications, encouraging more individuals to opt for these procedures. The number of workplace ankle and foot injuries has been growing since the past few years.
The bone replacement market share from the wrist and hand replacement segment is likely to expand owing to reduced bone mineral density, particularly amongst the ageing women population. Changes in lifestyles of this population segment has increased the risk of distal radius fracture, or wrist fractures. The global burden of bone fractures will support product adoption up to 2028. As per the data published by the United Nations (UN), the total number of geriatric individuals will cross 2.1 billion by 2050.
Asia Pacific bone replacement market size will grow at an appreciable CAGR through the assessment timeframe, supported by the alarming rise in arthritis patients. With the number of road accidents across India, China, Japan, Indonesia, and Australia rising continually, the need for hip and knee replacement surgeries has been growing. Unsafe road infrastructure and drink-driving are responsible for this trend. According to the WHO, over 93% of the global road fatalities occur across low- and middle-income countries.
Top bone replacement product manufacturers across the globe include Zimmer Biomet, Smith & Nephew Plc, B. Braun Melsungen AG, Medtronic, Stryker, and NuVasive. These firms have been working continuously to bring about innovative product launches and establish partnerships with other companies to consolidate their position in the industry.
Amidst the pandemic, the falling procedural volume hampered market growth. Several hospitals worldwide had put orthopedic surgeries on hold due to the unprecedented spike in COVID-19 patient admissions. Nevertheless, industry participants are developing products using next-generation biomaterials, considering the demographic shifts directly and indirectly associated with the pandemic. They are investing in new product launches to ensure a strong global presence.
For instance, in July 2021, Bioventus, Inc. launched a flowable allograft, OSTEOAMP SELECT Flowable. It is suitable for procedures including foot & ankle fusion, cervical spine fusion, and lumbar spine fusion.
Market, by material
Market, by type
Market, by extremities
Market, by end-use
The above information is provided for the following regions and countries: